Enid Shephard

2.6k total citations
77 papers, 2.1k citations indexed

About

Enid Shephard is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Enid Shephard has authored 77 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 26 papers in Molecular Biology and 22 papers in Epidemiology. Recurrent topics in Enid Shephard's work include HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (12 papers) and Adipokines, Inflammation, and Metabolic Diseases (8 papers). Enid Shephard is often cited by papers focused on HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (12 papers) and Adipokines, Inflammation, and Metabolic Diseases (8 papers). Enid Shephard collaborates with scholars based in South Africa, United States and United Kingdom. Enid Shephard's co-authors include Ralph E. Kirsch, Anna‐Lise Williamson, Simon C. Robson, Michelle M. Gehringer, Tim G. Downing, Frederick C. de Beer, Edward P. Rybicki, Pauline de la Μ. Hall, A F Strachan and Richard Kirsch and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Enid Shephard

76 papers receiving 2.1k citations

Peers

Countries citing papers authored by Enid Shephard

Since Specialization

Citations

This map shows the geographic impact of Enid Shephard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enid Shephard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enid Shephard more than expected).

Fields of papers citing papers by Enid Shephard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enid Shephard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enid Shephard. The network helps show where Enid Shephard may publish in the future.

Co-authorship network of co-authors of Enid Shephard

This figure shows the co-authorship network connecting the top 25 collaborators of Enid Shephard. A scholar is included among the top collaborators of Enid Shephard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enid Shephard. Enid Shephard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies 2017 ·Vaccine ·Gerald K. Chege, Wendy A. Burgers, (unknown), Clive M. Gray, Enid Shephard, Susan W. Barnett, Guido Ferrari, David C. Montefiori, Carolyn Williamson, Anna‐Lise Williamson	7
2	The Use of Directed Evolution to Create a Stable and Immunogenic Recombinant BCG Expressing a Modified HIV-1 Gag Antigen 2014 ·PLoS ONE ·Rosamund Chapman, William Bourn, Enid Shephard, (unknown), Nicola Douglass, (unknown), Ann E. Meyers, Nyasha Chin’ombe, Anna‐Lise Williamson	10
3	South African HIV-1 vaccine candidates - the journey from the bench to clinical trials : forum - reflections 2012 ·South African Medical Journal ·Anna‐Lise Williamson, Edward P. Rybicki, Enid Shephard, Linda‐Gail Bekker, Katrina Downing, Carolyn Williamson, Glenda Gray	6
4	Abrogation of contaminating RNA activity in HIV-1 Gag VLPs 2011 ·Virology Journal ·Ziyaad Valley‐Omar, Ann E. Meyers, Enid Shephard, Anna‐Lise Williamson, Edward P. Rybicki	22
5	The porcine circovirus type 1 capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccine 2011 ·Virology Journal ·(unknown), Enid Shephard, Kenneth E. Palmer, (unknown), Anna‐Lise Williamson, Edward P. Rybicki	19
6	A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV) 2011 ·Virology Journal ·(unknown), Enid Shephard, Nicola Douglass, (unknown), (unknown), Carolyn Williamson, Anna‐Lise Williamson	39
7	Recombinant Mycobacterium bovis BCG as an HIV Vaccine Vector 2010 ·Current HIV Research ·Rosamund Chapman, Gerald K. Chege, Enid Shephard, (unknown), Anna‐Lise Williamson	36
8	Use of the piggyBac transposon to create HIV-1 gag transgenic insect cell lines for continuous VLP production 2010 ·BMC Biotechnology ·(unknown), (unknown), Malcolm J. Fraser, Enid Shephard, Anna‐Lise Williamson, Edward P. Rybicki	22
9	A prime–boost immunisation regimen using recombinant BCG and Pr55gag virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons 2009 ·Vaccine ·Gerald K. Chege, (unknown), Enid Shephard, Ann E. Meyers, William Bourn, Carolyn Williamson, James Maclean, Clive M. Gray, Edward P. Rybicki, Anna‐Lise Williamson	28
10	Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles 2008 ·Virus Research ·(unknown), (unknown), Ann E. Meyers, Sirika Pillay, (unknown), Enid Shephard, Anna‐Lise Williamson, Edward P. Rybicki	23
11	Expression of HIV-1 antigens in plants as potential subunit vaccines 2008 ·BMC Biotechnology ·Ann E. Meyers, Ereck Chakauya, Enid Shephard, (unknown), James Maclean, (unknown), Anna‐Lise Williamson, Edward P. Rybicki	77
12	Rodent nutritional model of steatohepatitis: Effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency 2006 ·Journal of Gastroenterology and Hepatology ·Richard Kirsch, (unknown), Robert C. Verdonk, A. David Marais, Enid Shephard, Bernard Ryffel, Pauline de la Μ. Hall	42
13	Rodent nutritional model of non‐alcoholic steatohepatitis: Species, strain and sex difference studies 2003 ·Journal of Gastroenterology and Hepatology ·Richard Kirsch, (unknown), (unknown), Enid Shephard, David Marais, Mohamed Jaffer, (unknown), Ralph E. Kirsch, Pauline de la Μ. Hall	214
14	An investigation into the detoxification of microcystin-LR by the glutathione pathway in Balb/c mice 2003 ·The International Journal of Biochemistry & Cell Biology ·Michelle M. Gehringer, Enid Shephard, Tim G. Downing, Claudia Wiegand, Brett A. Neilan	119
15	Patients with stable uncomplicated cirrhosis have normal neutrophil function 2000 ·Journal of Gastroenterology and Hepatology ·Richard Kirsch, (unknown), Enid Shephard, Ralph E. Kirsch	11
16	Histopathology and gene expression changes in rat liver during feeding of fumonisin B1, a carcinogenic mycotoxin produced by Fusarium moniliforme 1999 ·Carcinogenesis ·Eric R. Lemmer, Pauline de la Μ. Hall, Nobuhiko Omori, Masako Omori, Enid Shephard, Wentzel C.A. Gelderblom, J.P. Cruse, (unknown), Walter F. O. Marasas, Ralph E. Kirsch, (unknown)	58
17	Changes in T-Cell Subsets After Renal Transplantation in Nonimmunosuppressed Baboons 1998 ·Transplantation Proceedings ·(unknown), Glenda M. Davison, J. A. Smit, Enid Shephard, Maureen Duffield, Jean Finlayson, I F McKenzie, D. Kahn	2
18	Digestion of 125I-labelled plasmin-derived fibrin degradation products by neutrophil lysosomal enzymes 1998 ·Blood Coagulation & Fibrinolysis ·(unknown), Steven L. Kelly, R. E. Kirsch, Enid Shephard	3
19	Fibronectin fragments cause an underestimation of plasma fibronectin levels in severe pre-eclampsia 1996 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Celeste A. de Jager, J Anthony, Simon C. Robson, Enid Shephard, R. E. Kirsch	3
20	Binding of human serum amyloid P component (hSAP) to human neutrophils 1994 ·European Journal of Biochemistry ·(unknown), (unknown), Michel Pontet, Mordechai Pras, (unknown), Enid Shephard, Mati Fridkin	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact